In his research, Wayne D. Tilley performs multidisciplinary study on Internal medicine and Oncology. Oncology and Cancer are two areas of study in which he engages in interdisciplinary work. Wayne D. Tilley combines Cancer and Hormone in his research. Wayne D. Tilley performs integrative Hormone and Endocrinology research in his work. Borrowing concepts from Internal medicine, Wayne D. Tilley weaves in ideas under Endocrinology. In his works, Wayne D. Tilley conducts interdisciplinary research on Prostate cancer and Prostate. In his work, he performs multidisciplinary research in Prostate and Androgen. Wayne D. Tilley brings together Androgen and Androgen receptor to produce work in his papers. Wayne D. Tilley merges Androgen receptor with Gene in his research.
Wayne D. Tilley connects Cancer with Pathology in his research. While working on this project, he studies both Pathology and Cancer. His research on Internal medicine often connects related areas such as Odds ratio. Wayne D. Tilley connects Prostate cancer with Cancer research in his research. He undertakes interdisciplinary study in the fields of Cancer research and Prostate cancer through his works. In his work, he performs multidisciplinary research in Androgen receptor and Transcription factor. In his works, he undertakes multidisciplinary study on Transcription factor and Androgen receptor. Wayne D. Tilley performs integrative study on Androgen and Prostate in his works. He performs multidisciplinary studies into Prostate and Androgen in his work.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Prostate cancer in a transgenic mouse.
N M Greenberg;F DeMayo;M J Finegold;D Medina.
Proceedings of the National Academy of Sciences of the United States of America (1995)
Progesterone receptor modulates ERα action in breast cancer
Hisham Mohammed;I. Alasdair Russell;Rory Stark;Oscar M. Rueda.
Characterization and expression of a cDNA encoding the human androgen receptor.
Wayne D. Tilley;Marco Marcelli;Jean D. Wilson;Michael J. McPhaul.
Proceedings of the National Academy of Sciences of the United States of America (1989)
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Fredrick R. Schumacher;Ali Amin Al Olama;Sonja I. Berndt;Sara Benlloch.
Nature Genetics (2018)
Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence.
Wayne D. Tilley;Grant Buchanan;Theresa E. Hickey;Jacqueline M. Bentel.
Clinical Cancer Research (1996)
Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer.
Amelia A. Peters;Grant Buchanan;Carmela Ricciardelli;Tina Bianco-Miotto.
Cancer Research (2009)
Dual Roles of PARP-1 Promote Cancer Growth and Progression
Matthew J. Schiewer;Jonathan F. Goodwin;Sumin Han;J. Chad Brenner.
Cancer Discovery (2012)
Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1
Jessica L L Robinson;Stewart MacArthur;Caryn S Ross‐Innes;Wayne D Tilley.
The EMBO Journal (2011)
Androgens induce divergent proliferative responses in human breast cancer cell lines
S.N. Birrell;J.M. Bentel;T.E. Hickey;C. Ricciardelli.
The Journal of Steroid Biochemistry and Molecular Biology (1995)
Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancer
Howard I Scher;Grant Buchanan;William Gerald;Lisa M Butler.
Endocrine-related Cancer (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: